Healthcare -
Biotechnology - NASDAQ - US
$ 1.95
0 %
$ 409 M
Market Cap
-1.26
P/E
ALLO - PRE-TAX INCOME
Pre-tax Income ALLO - Allogene Therapeutics, Inc.
-327 M
LAST VALUE
-12.84%
2 YEAR CAGR
-9.11%
5 YEAR CAGR
0.00%
10 YEAR CAGR